Transglutaminase Inhibition Reduces Fibrosis and Preserves Function in Experimental Chronic Kidney Disease
Open Access
- 1 December 2007
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 18 (12) , 3078-3088
- https://doi.org/10.1681/asn.2006070690
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growthCell Death & Differentiation, 2005
- Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000Journal of the American Society of Nephrology, 2005
- Transglutaminases in Wound Healing and InflammationPublished by S. Karger AG ,2005
- Inhibition of Transglutaminase Activity Reduces Extracellular Matrix Accumulation Induced by High Glucose Levels in Proximal Tubular Epithelial CellsPublished by Elsevier ,2004
- Importance of Tissue Transglutaminase in Repair of Extracellular Matrices and Cell Death of Dermal Fibroblasts After Exposure to a Solarium Ultraviolet A SourceJournal of Investigative Dermatology, 2003
- Transglutaminases: crosslinking enzymes with pleiotropic functionsNature Reviews Molecular Cell Biology, 2003
- Interferon-γ inhibits experimental renal fibrosisKidney International, 1999
- Regulation of Cell Surface Tissue Transglutaminase: Effects on Matrix Storage of Latent Transforming Growth Factor-β Binding Protein-1Journal of Histochemistry & Cytochemistry, 1999
- Cardiac Specific Overexpression of Transglutaminase II (Gh) Results in a Unique Hypertrophy Phenotype Independent of Phospholipase C ActivationJournal of Biological Chemistry, 1999
- Increase in ϵ(γ-glutamyl)lysine crosslinks in atherosclerotic aortasAtherosclerosis, 1994